迈博药业-B(02181)发布年度业绩 股东应占溢利5713.3万元 同比扭亏为盈

智通财经
Mar 26

智通财经APP讯,迈博药业-B(02181)发布截至2025年12月31日止年度业绩,营业收入6.46亿元(人民币,下同),同比增长150.2%;公司拥有人应占溢利5713.3万元,同比扭亏为盈;每股基本盈利0.01元。

公告称,股东应占溢利扭亏为盈主要是由于公司毛利增加以及将未来一年可抵扣的所得税确认为递延所得税费用所致。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10